According to Albireo Pharma's latest financial reports the company's current revenue (TTM ) is NZ$99.83 Million. In 2021 the company made a revenue of NZ$59.4 Million an increase over the revenue in the year 2020 that were of NZ$11.51 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2022 (TTM) | NZ$87.71 M | 47.65% |
2021 | NZ$59.4 M | 415.96% |
2020 | NZ$11.51 M | -19.52% |
2019 | NZ$14.3 M | -24.67% |
2018 | NZ$18.99 M | 1348790.08% |
2017 | NZ$0 M | |
2015 | N/A | |
2014 | N/A | |
2013 | N/A | |
2012 | N/A | |
2011 | N/A | |
2010 | N/A | |
2009 | N/A |